Tycho Baumann
Overview
Explore the profile of Tycho Baumann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
3188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lamaj G, Pablo-Trinidad A, Butterworth I, Bell N, Benasutti R, Bourquard A, et al.
J Med Internet Res
. 2022 Aug;
24(8):e37368.
PMID: 35943786
Background: Patients with cancer undergoing cytotoxic chemotherapy face an elevated risk of developing serious infection as a consequence of their treatment, which lowers their white blood cell count and, more...
12.
Bastidas-Mora G, Bea S, Navarro A, Gine E, Costa D, Delgado J, et al.
Br J Haematol
. 2021 Sep;
196(1):146-155.
PMID: 34519021
We describe 36 patients with splenic marginal zone lymphoma (SMZL) with transformation (SMZL-T), including 15 from a series of 84 patients with SMZL diagnosed at the Hospital Clinic of Barcelona...
13.
Rivero A, Mozas P, Jimenez L, Lopez-Guerra M, Colomer D, Bataller A, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359799
T-cell large granular lymphocytic leukemia (T-LGLL) and chronic lymphoproliferative disorder of natural killer (NK) cells are two infrequent diseases characterized by clonal expansions of cytotoxic T lymphocytes and NK cells,...
14.
Duran-Ferrer M, Clot G, Nadeu F, Beekman R, Baumann T, Nordlund J, et al.
Nat Cancer
. 2021 Jun;
1(11):1066-1081.
PMID: 34079956
We report a systematic analysis of the DNA methylation variability in 1,595 samples of normal cell subpopulations and 14 tumor subtypes spanning the entire human B-cell lineage. Differential methylation among...
15.
Ramos-Campoy S, Puiggros A, Bea S, Bougeon S, Larrayoz M, Costa D, et al.
Haematologica
. 2021 Mar;
107(3):593-603.
PMID: 33691382
Genome complexity has been associated with poor outcome in patients with chronic lymphocytic leukemia (CLL). Previous cooperative studies established five abnormalities as the cut-off that best predicts an adverse evolution...
16.
Mozas P, Rivero A, Rivas-Delgado A, Nadeu F, Correa J, Castillo C, et al.
Ann Hematol
. 2021 Feb;
100(5):1231-1239.
PMID: 33629152
Frailty and concurrent medical conditions are crucial factors in the management of follicular lymphoma (FL). We evaluated the impact of age and comorbidity on survival, causes of death, histological transformation...
17.
Baumann T, Moia R, Gaidano G, Delgado J, Condoluci A, Villamor N, et al.
Leukemia
. 2021 Feb;
35(8):2325-2331.
PMID: 33542480
The prognostic significance of lymphocyte doubling time (LDT) in chronic lymphocytic leukemia (CLL) was identified when the biology of the disease was poorly understood and therapy was not effective. We...
18.
Mozas P, Sorigue M, Rivas-Delgado A, Rivero A, Correa J, Castillo C, et al.
Eur J Haematol
. 2020 Nov;
106(3):428-432.
PMID: 33247499
No abstract available.
19.
Nadeu F, Royo R, Clot G, Duran-Ferrer M, Navarro A, Martin S, et al.
Blood
. 2020 Nov;
137(21):2935-2946.
PMID: 33211804
B-cell receptor (BCR) signaling is crucial for chronic lymphocytic leukemia (CLL) biology. IGLV3-21-expressing B cells may acquire a single point mutation (R110) that triggers autonomous BCR signaling, conferring aggressive behavior....
20.
Molica S, Baumann T, Giannarelli D
Eur J Haematol
. 2020 Nov;
106(3):425-427.
PMID: 33190324
No abstract available.